SCHEMBL4471113

SCHEMBL4471113

Cc1[nH]c(C)c(-c2c[nH]c(-c3cccc(OC(F)(F)F)c3)cc2=O)c(=O)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.40
KCNH2 Q12809 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.39
PIM1 P11309 4/20 0.36
PIM3 Q86V86 2/20 0.36
NPY5R Q15761 1/20 0.36
BACE1 P56817 1/20 0.36
PIM2 Q9P1W9 3/20 0.36
PDE10A Q9Y233 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
TRPC5 Q9UL62 1/20 0.35
PTGES O14684 1/20 0.35
PTGS1 P23219 1/20 0.35
CTSA P10619 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
FFAR1 O14842 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4490716 0.90 SCN10A (0.37) KCNH2SCN10APTGES
Hydrochloric Acid SCHEMBL4489667 0.89 SCN10A (0.36) KCNH2SCN10APIM2PTGES
SCHEMBL4492022 0.85 MAPT (0.41) XDHNPY5RTHRBALDH1A1LMNA
SCHEMBL4490544 0.83 BRD4 (0.39) PIM1
SCHEMBL4491166 0.82 POLB (0.37) CTSAFFAR1
SCHEMBL4565035 0.80 TNKS (0.39) NPY5RALDH1A1
SCHEMBL4480202 0.80 SCN9A (0.36)
SCHEMBL4471107 0.79 XDH (0.45) XDHKCNH2SCN10ANPY5RCTSA
SCHEMBL4481795 0.79 ALDH1A1 (0.43) THRBALDH1A1LMNA
SCHEMBL4481805 0.78 SLC2A1 (0.38) KCNH2FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US claimed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US claimed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
EP-1858876-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2007-11-28 EP disclosed
WO-2006094799-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2006-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP XDH 198/4885KCNH2 1502/4885SCN10A 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.